Patent foramen ovale transcatheter closure device thrombosis

Mayo Clinic Proceedings

Volumn 76, Issue 10, 2001, Pages 1057-1061

  Nkomo, Vuyisile T ^a   Theuma, Pierre ^a   Maniu, Calin V ^a   Chandrasekaran, Krishnaswamy ^a   Miller, Fletcher A ^a   Schaff, Hartzell V ^a   Petty, George W ^a   Miller, Todd D ^a  

^a MAYO CLINIC   (United States)

Author keywords

APC R = activated protein C resistance; ASD = atrial septal defect; DVT = deep venous thrombosis; INR = international normalized ratio; PFO = patent foramen ovale; TEE = transesophageal echocardiography; TIA = transient ischemic attack; TTE = transthoracic echocardiography

Indexed keywords

ACETYLSALICYLIC ACID; WARFARIN;

ADULT; ARTICLE; CASE REPORT; DEVICE; FEMALE; HEADACHE; HEART ATRIUM SEPTUM DEFECT; HEART PALPITATION; HEART RIGHT LEFT SHUNT; HUMAN; PHOTOPHOBIA; STROKE; THROMBOSIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; VISUAL IMPAIRMENT;

EID: 0034783938     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/76.10.1057     Document Type: Article

References (37)

1. Transcatheter closure of atrial septal defects in adults with the Amplatzer septal occluder
2. Closure of patent foramen ovale for paradoxical emboli: Intermediate-term risk of recurrent neurological events following transcatheter device placement
3. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: Long-term risk of recurrent thromboembolic events
4. Images in cardiothoracic surgery: Thrombus formation after catheter closure of an atrial septal defect with a clamshell device
5. Paradoxical embolism
6. Paradoxical arterial embolism: Collective review
7. Paradoxical embolism: Diagnosis during life
8. The adverse effects of hormone replacement therapy
9. Hormone therapy to prevent disease and prolong life in postmenopausal women
10. The HERS trial results: Paradigms lost? Heart and Estrogen/progestin Replacement study
11. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women
12. Risk of venous thromboembolism in users of hormone replacement therapy
13. Frequency of deep vein thrombosis in patients with patent foramen ovale and ischemic stroke or transient ischemic attack
14. Resistance to activated protein C as a basis for venous thrombosis
15. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
16. Women with thrombophilia: Assessing the risks for thrombosis with oral contraceptives or hormone replacement therapy
17. Patent foramen ovale in patients with cerebral infarction: A transesophageal echocardiographic study
18. Patent foramen ovale and brain infarct: Echocardiographic predictors, recurrence, and prevention
19. Surgical closure of patent foramen ovale in cryptogenic stroke patients
20. Transesophageal echocardiography and carotid ultrasound in patients with cerebral ischemia: Prevalence of findings and recurrent stroke risk
21. Recurrent cerebrovascular events in patients with patent foramen ovale, atrial septal aneurysm, or both and cryptogenic stroke or transient ischemic attack
22. The Amplatzer septal occluder
23. Per-catheter ASD closure
24. Transcatheter closure of patent foramen ovale in patients with cryptogenic stroke
25. Transcatheter closure of atrial septal defects: Experimental studies
26. Transcatheter closure of patent foramen ovale after presumed paradoxical embolism
27. Transcatheter closure of secundum atrial septal defects with the atrial septal defect occlusion system (ASDOS): Initial experience in children
28. Transcatheter closure of atrial septal defect or patent foramen ovale with the buttoned device for prevention of recurrence of paradoxic embolism
29. The role of CardioSEAL and Starflex devices in atrial defect occlusion
30. Intermediate-term outcome of transcatheter secundum atrial septal defect closure using the Bard Clamshell Septal Umbrella
31. Transcatheter closure of atrial septal defect and patent foramen ovale with ASDOS device (a multi-institutional European trial)
32. Surgical removal of atrial septal defect occlusion system-devices
33. Thrombus formation on transcatheter ASD occluder device in a patient with coagulation factor XII deficiency
34. A European multicentric experience using the CardioSEAL and Starflex double umbrella devices to close interatrial communications holes within the oval fossa
35. Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses